ATE242625T1 - Chelat-zubereitungen, die oximverbindungen enthalten - Google Patents

Chelat-zubereitungen, die oximverbindungen enthalten

Info

Publication number
ATE242625T1
ATE242625T1 AT91908813T AT91908813T ATE242625T1 AT E242625 T1 ATE242625 T1 AT E242625T1 AT 91908813 T AT91908813 T AT 91908813T AT 91908813 T AT91908813 T AT 91908813T AT E242625 T1 ATE242625 T1 AT E242625T1
Authority
AT
Austria
Prior art keywords
group
alkyl
heteroaryl
aryl
hydrogen
Prior art date
Application number
AT91908813T
Other languages
English (en)
Inventor
Rodney Dean Bush
Donald Lynn Bissett
Ranjit Chatterjee
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE242625T1 publication Critical patent/ATE242625T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/36—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/38—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51—Chelating agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT91908813T 1990-04-26 1991-04-09 Chelat-zubereitungen, die oximverbindungen enthalten ATE242625T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51499890A 1990-04-26 1990-04-26
US65784791A 1991-02-25 1991-02-25
PCT/US1991/002398 WO1991016034A1 (en) 1990-04-26 1991-04-09 Chelator compositions comprising oxime compounds

Publications (1)

Publication Number Publication Date
ATE242625T1 true ATE242625T1 (de) 2003-06-15

Family

ID=27058372

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91908813T ATE242625T1 (de) 1990-04-26 1991-04-09 Chelat-zubereitungen, die oximverbindungen enthalten

Country Status (8)

Country Link
US (1) US5364617A (de)
EP (1) EP0611301B1 (de)
AT (1) ATE242625T1 (de)
AU (1) AU662101B2 (de)
CA (1) CA2079485C (de)
DE (1) DE69133277T2 (de)
ES (1) ES2199214T3 (de)
WO (1) WO1991016034A1 (de)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439954A (en) * 1991-10-11 1995-08-08 The Procter & Gamble Company Substituted phenyl-1,3-diketones as protectants against skin damage
US5686436A (en) * 1993-05-13 1997-11-11 Hiv Diagnostics, Inc. Multi-faceted method to repress reproduction of latent viruses in humans and animals
WO1995001157A1 (en) * 1993-06-29 1995-01-12 The Procter & Gamble Company Use of hydroxyphenyl oximes as chelating photoprotectants
JP2001508755A (ja) * 1994-04-08 2001-07-03 ザ、プロクター、エンド、ギャンブル、カンパニー 哺乳動物でラジカルダメージを減少させるために鉄キレート化合物を用いる方法
US5922758A (en) * 1994-09-21 1999-07-13 The Procter & Gamble Company Methods and compositions employing 2,4-dienoic acid esters of tocopherols to prevent or reduce skin damage
US5739156A (en) * 1994-09-21 1998-04-14 The Procter & Gamble Company Methods of using 2,4-dienoic acid esters of tocopherols to reduce free radical damage in mammalian cells
US5624664A (en) * 1995-01-30 1997-04-29 Lambrechts; John Skin conditioning composition and softgel filled therewith
EP0843548A4 (de) * 1995-06-07 1998-10-28 Rhone Poulenc Rorer Pharma Stabilisierte steroidhaltige mittel
FR2755011B1 (fr) * 1996-10-31 1998-11-20 Cird Galderma Utilisation des inhibiteurs de l'activite de l'acide retinoique pour traiter les peaux sensibles et/ou les dommages aigus induits par les rayonnements u.v.
US5804168A (en) * 1997-01-29 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for protecting and treating sun damaged skin
TWI234467B (en) * 1997-06-04 2005-06-21 Univ Michigan Composition for inhibiting photoaging of skin
US5829449A (en) * 1997-09-19 1998-11-03 Thione International, Inc. Smoking products containing antioxidants
KR20020047129A (ko) * 1999-08-24 2002-06-21 데이비드 엠 모이어 옥심 화합물 함유 조성물의 국소 적용에 의한 케라틴성조직의 라이트닝 방법
DE10031703A1 (de) * 2000-06-29 2002-01-10 Beiersdorf Ag Verwendung von Calcium freisetzenden oder bindenden Substanzen zur gezielten Schächung oder Stärkung der Barrierefunktion der Haut
US6481442B1 (en) 2000-11-28 2002-11-19 Lorillard Licensing Company, Llc Smoking article including a filter for selectively removing carbonyls
AU2002220121A1 (en) * 2000-11-28 2002-06-11 Lorillard Licensing Company, Llc A smoking article including a selective carbon monoxide pump
US6677294B2 (en) 2000-11-29 2004-01-13 The Procter & Gamble Company Cleansing compositions
ITPI20010014A1 (it) * 2001-03-05 2002-09-05 Ivo Pera Composto per filtri per sigarette,o altri articoli da fumo,a base di sostanze antiossidanti ed il filtro cosi'ottenuto
US20020182237A1 (en) 2001-03-22 2002-12-05 The Procter & Gamble Company Skin care compositions containing a sugar amine
US20050281766A1 (en) * 2002-03-11 2005-12-22 Avon Products, Inc. Method of improving the aesthetic appearance of epithelia
US7235249B2 (en) 2002-03-28 2007-06-26 The Procter & Gamble Company Methods for regulating the condition of mammalian keratinous tissue via topical application of vitamin B6 compositions
US7098189B2 (en) 2002-12-16 2006-08-29 Kimberly-Clark Worldwide, Inc. Wound and skin care compositions
EP1572147A1 (de) 2002-12-20 2005-09-14 The Procter & Gamble Company Textilartige körperpflegeartikel
US20040175347A1 (en) 2003-03-04 2004-09-09 The Procter & Gamble Company Regulation of mammalian keratinous tissue using hexamidine compositions
US20050003024A1 (en) 2003-03-04 2005-01-06 The Procter & Gamble Company Regulation of mammalian hair growth
US8734421B2 (en) 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
KR101045658B1 (ko) 2003-11-17 2011-07-01 쎄데르마 테트라펩티드 및 트리펩티드 혼합물을 포함하는 조성물
US20070191368A1 (en) * 2004-03-23 2007-08-16 Bissett Donald L Inhibition of tissue damage to skin from radiation treatment therapy
US7485666B2 (en) 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
FR2880802B1 (fr) 2005-01-14 2008-12-19 Sederma Soc Par Actions Simpli Composition cosmetique ou dermopharmaceutique contenant un extrait d'euglene
US8147853B2 (en) 2005-02-15 2012-04-03 The Procter & Gamble Company Personal care compositions containing hydrophobically modified non-platelet particles
FR2890310B1 (fr) 2005-09-06 2009-04-03 Sederma Soc Par Actions Simpli Utilisation des protoberberines comme agents regulant l'activite de l'unite pilosebacee
US7614812B2 (en) 2005-09-29 2009-11-10 Kimberly-Clark Worldwide, Inc. Wiper with encapsulated agent
US7485609B2 (en) * 2005-09-29 2009-02-03 Kimberly-Clark Worldwide, Inc. Encapsulated liquid cleanser
EP3015101B1 (de) 2005-10-03 2019-08-21 PINSKY, Mark A. Non-phospholipid liposomen enthaltend hyaluronsäure
FR2900573B1 (fr) 2006-05-05 2014-05-16 Sederma Sa Nouvelles compositions cosmetiques renfermant au moins un peptide contenant au moins un cycle aromatique bloque
CN100475189C (zh) 2006-10-17 2009-04-08 王海龙 一种化妆品组合物及其制备方法和应用
EP2754445A3 (de) 2007-09-28 2014-08-27 Johnson & Johnson Consumer Companies Inc. Stromerzeugende Teilchen zur Behandlung von exzessivem Schwitzen
US20090187060A1 (en) 2008-01-22 2009-07-23 E-Z-Em, Inc. Method and Formulation for Neutralizing Toxic Chemicals and Materials
FR2939799B1 (fr) 2008-12-11 2011-03-11 Sederma Sa Composition cosmetique comprenant des oligoglucuronanes acetyles.
EP3744729B1 (de) 2009-01-16 2023-03-01 Sederma Peptide, zusammensetzungen damit und kosmetische und dermopharmazeutische verwendungen
FR2941231B1 (fr) 2009-01-16 2016-04-01 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
FR2941232B1 (fr) 2009-01-16 2014-08-08 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
FR2944435B1 (fr) 2009-04-17 2011-05-27 Sederma Sa Composition cosmetique comprenant de l'oridonine
FR2945939B1 (fr) 2009-05-26 2011-07-15 Sederma Sa Utilisation cosmetique du dipeptide tyr-arg pour lutter contre le relachement cutane.
US8859235B2 (en) 2009-08-14 2014-10-14 Basf Se Methods in cell cultures, and related inventions, employing certain additives
KR101701548B1 (ko) 2009-10-06 2017-02-01 바스프 에스이 벤조트로폴론을 함유하는 식물 추출물 및/또는 관련 벤조트로폴론 유도체의 사용에 의한 가정용 제품, 바디-관리 제품 및 식품의 안정화
US8933131B2 (en) 2010-01-12 2015-01-13 The Procter & Gamble Company Intermediates and surfactants useful in household cleaning and personal care compositions, and methods of making the same
BR112012031623B1 (pt) 2010-06-11 2018-04-10 The Procter & Gamble Company Composição para cuidados pessoais e seu uso
CN103687583B (zh) 2010-07-15 2016-08-17 宝洁公司 清洁毛发的方法
US20120172281A1 (en) 2010-07-15 2012-07-05 Jeffrey John Scheibel Detergent compositions comprising microbially produced fatty alcohols and derivatives thereof
BR112013001691A2 (pt) 2010-07-23 2016-05-24 Johnson & Johnson Consumer particulados de metal geradores de corrente de corrosão e uso dos mesmos
DE102010045890A1 (de) * 2010-09-17 2012-03-22 Merck Patent Gmbh 2,2'-Furoin-Derivte und deren Verwendung zur Hautaufhellung
US20140328952A1 (en) 2011-12-21 2014-11-06 Dana FLAVIN Topical compositions
US8895041B2 (en) 2012-03-23 2014-11-25 The Procter & Gamble Company Compositions for delivering perfume to the skin
US20140255330A1 (en) 2013-03-05 2014-09-11 The Procter & Gamble Company Mixed Sugar Compositions
EP2857004B1 (de) 2013-10-07 2018-07-04 The Procter and Gamble Company Haarglättungsverfahren mit reduzierenden Zuckern
EP3080142B1 (de) 2013-12-10 2018-01-31 Sussex Research Laboratories Inc. Glycopeptidzusammensetzungen und verwendungen davon
MX361102B (es) 2013-12-19 2018-11-27 Procter & Gamble Modelado de fibras de queratina con el uso de un agente activo que comprende al menos dos grupos funcionales seleccionados de: -c(oh)- y -c(=o)oh.
US11110046B2 (en) 2013-12-19 2021-09-07 The Procter And Gamble Company Shaping keratin fibres using 2-hydroxypropane-1,2,3-tricarboxylic acid and/or 1,2,3,4-butanetetracarboxylic acid
JP6334709B2 (ja) 2013-12-19 2018-05-30 ザ プロクター アンド ギャンブル カンパニー カルボネートエステルを使用したケラチン繊維の真直化方法
WO2015094760A1 (en) 2013-12-19 2015-06-25 The Procter & Gamble Company Shaping keratin fibres using carbonate ester
EP3082735B1 (de) 2013-12-19 2018-05-02 The Procter and Gamble Company Formung von keratinfasern mit oxoethansäure und/oder derivaten davon
EP3082733A1 (de) 2013-12-19 2016-10-26 The Procter & Gamble Company Formgebung von keratinfasern mit einem wirkstoff mit einer aus einer aus -c(= o) -, -c (= o) -h, -c und (= o) -o-bestehenden gruppe ausgewählten funktionellen gruppe
WO2015094756A1 (en) 2013-12-19 2015-06-25 The Procter & Gamble Company Shaping keratin fibres using an amine or a diamine
JP6385438B2 (ja) 2013-12-19 2018-09-05 ザ プロクター アンド ギャンブル カンパニー 糖類を使用したケラチン繊維の成形
WO2015191449A2 (en) 2014-06-08 2015-12-17 Solazyme, Inc. Personal care products containing microalgae or extracts thereof
US20160000682A1 (en) 2014-07-02 2016-01-07 Geoffrey Brooks Consultants Llc Peptide-Based Compositions and Methods of Use
US10966916B2 (en) 2014-11-10 2021-04-06 The Procter And Gamble Company Personal care compositions
US10085924B2 (en) 2014-11-10 2018-10-02 The Procter & Gamble Company Personal care compositions
US11207248B2 (en) 2014-11-10 2021-12-28 The Procter And Gamble Company Personal care compositions with two benefit phases
MX376115B (es) 2014-11-10 2025-03-07 Procter & Gamble Composiciones para el cuidado personal con dos fases benéficas.
WO2016100257A1 (en) 2014-12-19 2016-06-23 The Procter & Gamble Company Shaping keratin fibres using arabinose and ethylene carbonate
CN107106438A (zh) 2014-12-19 2017-08-29 宝洁公司 成形角蛋白纤维的方法
CN107106450B (zh) 2014-12-19 2020-12-01 宝洁公司 利用阿拉伯糖和碳酸亚乙酯使角蛋白纤维成形
MX2017016152A (es) 2015-06-18 2018-04-18 Procter & Gamble Modelado de fibras de queratina mediante el uso de compuestos de dialdehido.
MX372578B (es) 2015-06-18 2020-04-16 Procter & Gamble Modelado de fibras de queratina mediante el uso de compuestos de 2-oxazolidinona
CN105267066B (zh) 2015-10-08 2019-06-11 知识产权全资有限公司 用于处理头发的方法及其试剂盒
CN105902404A (zh) 2016-06-14 2016-08-31 知识产权全资有限公司 强发成分以及强发的方法
CN111494227A (zh) 2016-05-19 2020-08-07 知识产权全资有限公司 强发成分以及强发的方法
CN106265109A (zh) 2016-08-22 2017-01-04 知识产权全资有限公司 强发成分以及强发并使头发具有极佳手感的方法
WO2019079405A1 (en) 2017-10-20 2019-04-25 The Procter & Gamble Company AEROSOL FOAMING CLEANSER FOR THE SKIN
WO2019079409A1 (en) 2017-10-20 2019-04-25 The Procter & Gamble Company CLEANER FOR AEROSOL MOUSSE FOAM
EP3720568B1 (de) 2017-12-08 2022-01-12 The Procter & Gamble Company Screening-verfahren für milde hautreiniger
BE1026073B1 (nl) * 2018-03-05 2019-10-07 Purna Pharmaceuticals Nv Verbeterde werkwijze voor het maken van een farmaceutische emulsie
US10369396B1 (en) 2018-11-09 2019-08-06 Battelle Memorial Institute Assembly for decontaminating and method of manufacturing the assembly
WO2020112486A1 (en) 2018-11-29 2020-06-04 The Procter & Gamble Company Methods for screening personal care products

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058886A (en) * 1957-08-20 1962-10-16 Dyk & Company Inc Van Skin-protecting sunscreening process
US3836528A (en) * 1968-07-23 1974-09-17 Dainippon Pharmaceutical Co Alpha-(5-nitro-2-furyl)nitrones
CA1138474A (en) * 1978-03-08 1982-12-28 Riekert Kok Process for the preparation of a 1,2-dioxime
US4401649A (en) * 1981-07-20 1983-08-30 Polaroid Corporation Sunscreen method
DE3856315T2 (de) * 1987-10-22 1999-10-14 The Procter & Gamble Co. Chelatbildner enthaltende Lichtschutzmittel
US5155110A (en) * 1987-10-27 1992-10-13 Warner-Lambert Company Fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition

Also Published As

Publication number Publication date
ES2199214T3 (es) 2004-02-16
WO1991016034A1 (en) 1991-10-31
DE69133277T2 (de) 2004-04-08
AU7756591A (en) 1991-11-11
DE69133277D1 (de) 2003-07-17
CA2079485A1 (en) 1991-10-27
US5364617A (en) 1994-11-15
EP0611301A4 (de) 1993-03-01
AU662101B2 (en) 1995-08-24
EP0611301B1 (de) 2003-06-11
CA2079485C (en) 1999-05-11
EP0611301A1 (de) 1994-08-24

Similar Documents

Publication Publication Date Title
DE69133277D1 (de) Chelat-zubereitungen, die oximverbindungen enthalten
ATE195247T1 (de) Chelat-zubereitung, die alpha-diamin-verbindungen enthalten
NO171684C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktiv polyetylenglykolkarbaminater
NO981269L (no) Forbindelser som forsterker virkningen av retinoider
AU547674B2 (en) 1,2,6-thiadiazine-3,5-dione-1,1-dioxides
SE8302693D0 (sv) Heterocyclische verbindungen
DK0447285T3 (da) Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
BR9303993A (pt) Composto, processo para preparar o mesmo e composição farmacêutica
NZ231983A (en) Substituted 1,3-diazoles and 1,2,4-triazoles; fungicidal compositions, methods for preparation and combating fungal disease
ATE224T1 (de) 1,2-dihydro-chinolin-2-on-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel.
DE59108530D1 (de) Antimikrobielle Mittel sowie substituierte 2-Cyclohexan-1-yl-amin-Derivate und deren Herstellung
SE8204237L (sv) Karbostyrilforeningar, kompositioner innehallande dessa samt forfaranden for framstellning derav
ATE69239T1 (de) Oligopeptidylnitrilderivate, diese enthaltende mittel, verfahren zu ihrer herstellung und ihre verwendung.
BR8802021A (pt) Agentes repelentes de insetos e de acaros,processos para o combate a insetos e acaros e para a preparacao de agentes derivados e processo para sua preparacao
ATE168105T1 (de) Melamine derivate zur verwendung in der behandlung von krebs
DK602283D0 (da) Diethylaminoalkoxybenzhydrolderivater
FI812804L (fi) 2-(1,4-bensodioxan-2-ylalkyl)-imidazoler anvaendbara som antidepressiva laekemedel
BR9305752A (pt) Composto composiçao farmaceutica e processo para a preparaçao de um composto de derivados alquila da trazodona
ES2073460T3 (es) Fenilalquilaminas y los fungicidas que las contienen.
ES2078651T3 (es) Compuesto de piridinsulfonamida sustituida o una sal del mismo, procedimiento para su preparacion y herbicida que lo contiene.
DE69106323D1 (de) Imidazol-Derivate, Verfahren zu deren Herstellung und diese enthaltende Zusammenstellungen.
SE8504346L (sv) N-alkyl(en)-n-(o,o-disubstituerad tiofosforyl)-n',n'-disubstituerade glycinamider, sett att framstella dessa samt akaricid, insekticid och fungicid, innehallande dess foreningar som verksam bestandsdel
NO964735L (no) Adenosin-derivater
NO933691L (no) Tiokarbamatsulfoksydsammensetning for avholdenhet fra inntakelse av etanol
ES8106537A1 (es) Procedimiento de preparacion de nuevos fosfatos de n-(fenilosubstituido)-n-(alcoxicarbonilalcohil)-acetamidas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties